Literature DB >> 18704759

The FAP self-concept scale (adult form).

Mary Jane Esplen1, Noreen Stuckless, Terri Berk, Kate Butler, Steve Gallinger.   

Abstract

UNLABELLED: Familial Adenomatous Polyposis (FAP) is a dominantly inherited disorder characterized by multiple colorectal adenomas associated with a 100% risk of early colorectal cancer. A diagnosis of FAP may alter a person's self-concept, which in turn may impact on an individual's quality of life and screening behaviors.
PURPOSE: The purpose of the study was to develop and validate a scale for measuring the impact of being diagnosed with FAP on an individual's self-concept.
METHODS: The study was conducted in two phases: Phase (1) Item generation and refinement, and Phase (2) Scale selection and initial validation. Adults age 18 and older.
RESULTS: During Phase 1, scale items were generated through individual interviews and two professionally led focus groups. In Phase 2, 132/200 (66%) participants completed the 41-item candidate scale and a battery of standardized validating measures. The mean age of participants was 48 (12.2) years (range 21-74), 57% were female, 72% were married and 69% were Anglo-Canadian. The study resulted in a 23-item valid and reliable scale, Cronbach's alpha = .92, inter-item correlation = .34, total variance explained = 52.6%, low correlation with social desirability, and expected relationships with the other validating measures. Factor analysis resulted in three subscales representing the dimensions of stigma, self-esteem and mastery.
CONCLUSIONS: A promising new scale for measuring self-concept among adults with FAP has been developed. The instrument has potential use as a clinical screening tool and a research measure that will contribute to the empirical and theoretical literature.

Entities:  

Mesh:

Year:  2008        PMID: 18704759     DOI: 10.1007/s10689-008-9204-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  42 in total

1.  The assessment of trust orientation.

Authors:  L L Couch; J M Adams; W H Jones
Journal:  J Pers Assess       Date:  1996-10

2.  American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing.

Authors: 
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

Authors:  Iris van Oostrom; Hanne Meijers-Heijboer; Hugo J Duivenvoorden; Annette H J T Bröcker-Vriends; Christi J van Asperen; Rolf H Sijmons; Caroline Seynaeve; Arthur R Van Gool; Jan G M Klijn; Aad Tibben
Journal:  Patient Educ Couns       Date:  2006-07-26

Review 4.  Schema model of the self-concept.

Authors:  K F Stein
Journal:  Image J Nurs Sch       Date:  1995

Review 5.  Familial adenomatous polyposis: The practical applications of clinical and molecular screening.

Authors:  Paul Rozen; Finlay Macrae
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

6.  Psychosocial impact of illness intrusiveness moderated by self-concept and age in end-stage renal disease.

Authors:  G M Devins; H Beanlands; H Mandin; L C Paul
Journal:  Health Psychol       Date:  1997-11       Impact factor: 4.267

Review 7.  Body image after bilateral prophylactic mastectomy: an integrative literature review.

Authors:  Amy McGaughey
Journal:  J Midwifery Womens Health       Date:  2006 Nov-Dec       Impact factor: 2.388

8.  Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

Authors:  N Hallowell; C Foster; R Eeles; A Ardern-Jones; M Watson
Journal:  Soc Sci Med       Date:  2004-08       Impact factor: 4.634

9.  Self-surveillance for genetic predisposition to cancer: behaviors and emotions.

Authors:  Ellen Giarelli
Journal:  Oncol Nurs Forum       Date:  2006-11-03       Impact factor: 2.172

View more
  6 in total

1.  Survivor centrality among breast cancer survivors: implications for well-being.

Authors:  Vicki S Helgeson
Journal:  Psychooncology       Date:  2011-05       Impact factor: 3.894

2.  Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Authors:  M J Esplen; N Stuckless; S Gallinger; M Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; J Green; K Butler; H V Petersen; J Wong
Journal:  Clin Genet       Date:  2011-10-03       Impact factor: 4.438

3.  Validation of a self-concept scale for Lynch syndrome in different nationalities.

Authors:  Helle Vendel Petersen; Katarina Domanska; Pär-Ola Bendahl; Jiahui Wong; Christina Carlsson; Inge Bernstein; Mary Jane Esplen; Mef Nilbert
Journal:  J Genet Couns       Date:  2011-01-26       Impact factor: 2.537

4.  Facilitators and Challenges in Psychosocial Adaptation to Being at Increased Familial Risk of Breast Cancer.

Authors:  Louise Heiniger; Melanie A Price; Margaret Charles; Phyllis N Butow
Journal:  J Genet Couns       Date:  2015-03-05       Impact factor: 2.537

5.  Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study.

Authors:  Helle Vendel Petersen; Mary Jane Esplen; Steen Ladelund; Inge Bernstein; Lone Sunde; Christina Carlsson; Mef Nilbert
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

6.  Sense of coherence and self-concept in Lynch syndrome.

Authors:  Helle Vendel Petersen; Steen Ladelund; Christina Carlsson; Mef Nilbert
Journal:  Hered Cancer Clin Pract       Date:  2013-07-05       Impact factor: 2.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.